Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil
Introduction: In recent years, new technologies - noticeably ultra-portable echocardiographic machines - have emerged, allowing for Rheumatic Heart Disease (RHD) early diagnosis. We aimed to perform a cost-utility analysis to assess the cost-effectiveness of RHD screening with handheld devices in th...
Saved in:
Main Authors: | Jasper Ubels (Author), Craig Sable (Author), Andrea Z. Beaton (Author), Maria Carmo P. Nunes (Author), Kaciane K. B. Oliveira (Author), Lara C. Castro (Author), Isabella M. Teixeira (Author), Gabriela Z. L. Ruiz (Author), Letícia Maria M. Rabelo (Author), Alison R. Tompsett (Author), Antonio Luiz P. Ribeiro (Author), Klas-Göran Sahlen (Author), Bruno R. Nascimento (Author), On behalf of the PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e Outras Doenças Cardiovasculares) (Author) |
---|---|
Format: | Book |
Published: |
Ubiquity Press,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Buttonhole: Provare O Non Provare?
by: Luigi Tazza, et al.
Published: (2014) -
The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts
by: Mirela Costa de Miranda, et al.
Published: (2021) -
Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: A follow up study
by: Costa e Forti Adriana, et al.
Published: (2008) -
Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases' costs in Brazil)
by: Élide Sbardellotto M. da Costa, et al.
Published: (2021) -
Women's attitude towards prenatal screening for red blood cell antibodies, other than RhD
by: van der Schoot CE, et al.
Published: (2008)